| Samuel Robert Neely, | |
|
950 Walnut Bottom Rd, Carlisle, PA 17015-7636 | |
| (717) 258-1280 | |
| Not Available |
| Full Name | Samuel Robert Neely |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 950 Walnut Bottom Rd, Carlisle, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124621669 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | RP036744L (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Samuel Robert Neely, 950 Walnut Bottom Rd, Carlisle, PA 17015-7636 Ph: (717) 258-1280 | Samuel Robert Neely, 950 Walnut Bottom Rd, Carlisle, PA 17015-7636 Ph: (717) 258-1280 |
News Archive
The Washington Post reports that regulators are "trying to resolve" which insurance plans must comply with the health law's new requirements. "In keeping with President Obama's promise that you can hold on to your insurance if you like it, the new law exempts existing health plans from many of its provisions. But the law leaves it to regulators to decide how much a health plan can change without giving up its grandfathered status."
Delcath Systems, Inc., a development stage, oncology-focused, specialty pharmaceutical and medical device company, announced that its Phase III National Cancer Institute (NCI)-led multi-center clinical trial has successfully met the study's primary endpoint of extended hepatic progression-free survival (hPFS) in patients with melanoma metastases to the liver based on an independently corroborated intent-to-treat analysis.
Taligen Therapeutics, a biotechnology company developing therapies that regulate the complement system to treat inflammatory and immune diseases, announced today that the U.S. Patent and Trademark Office has issued U.S. Patent No. 7,759,304, entitled "Targeting Complement Factor H For Treatment of Diseases", covering the composition of matter for its lead product candidate, TT30, a novel fusion protein that selectively binds to complement activated cells to locally regulate the complement system.
Unless you find more realistic ways of paying for the promises included in the bill, you are simply setting up the public for more frustration - and yourselves for a political backlash (David Broder, 11/13).
About the looming debt and deficit issues in Congress, Obama blasted the ongoing Republican insistence that his signature health care law get defunded as part of a deal to raise the debt ceiling. "I think it's fair to say that never in history have we used just making sure that the U.S. government is paying its bills as a lever to radically cut government at the kind of scale that they're talking about," Obama said. "It's never happened before.
› Verified 5 days ago
Amanda C Wilston, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 351 E High St, Carlisle, PA 17013 Phone: 717-245-2541 | |
Sydney Anne Stuyvesant, PHARMD, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 60 Noble Blvd, Carlisle, PA 17013 Phone: 717-258-4252 | |
Mr. Robert Gerald Brockley, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 270 Lamplite Dr, Carlisle, PA 17013 Phone: 717-245-0352 | |
Shelly K King, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 233 E High St, Carlisle, PA 17013 Phone: 717-243-9100 Fax: 717-243-8732 | |
Dr. Michael Lehr, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1 Sprint Drive, English, Carlisle, PA 17015 Phone: 717-448-1868 | |
Nkohoua Yang, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1814 Spring Rd, Carlisle, PA 17013 Phone: 717-249-7697 | |
Dr. Kevin Tang, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 320 York Rd, Carlisle, PA 17013 Phone: 717-245-0116 |